Compare NLY & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NLY | WST |
|---|---|---|
| Founded | 1996 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3B | 18.7B |
| IPO Year | 1997 | N/A |
| Metric | NLY | WST |
|---|---|---|
| Price | $22.97 | $230.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 7 |
| Target Price | $23.55 | ★ $338.00 |
| AVG Volume (30 Days) | ★ 9.1M | 963.4K |
| Earning Date | 01-28-2026 | 02-12-2026 |
| Dividend Yield | ★ 12.17% | 0.38% |
| EPS Growth | ★ 80.25 | 0.17 |
| EPS | 2.92 | ★ 6.75 |
| Revenue | $2,304,722,000.00 | ★ $3,017,900,000.00 |
| Revenue This Year | $166.06 | $6.97 |
| Revenue Next Year | $9.61 | $6.27 |
| P/E Ratio | ★ $7.88 | $34.46 |
| Revenue Growth | ★ 84.69 | 4.92 |
| 52 Week Low | $16.60 | $187.43 |
| 52 Week High | $24.52 | $347.85 |
| Indicator | NLY | WST |
|---|---|---|
| Relative Strength Index (RSI) | 43.52 | 27.57 |
| Support Level | $23.56 | $232.06 |
| Resistance Level | $24.52 | $243.91 |
| Average True Range (ATR) | 0.49 | 9.07 |
| MACD | -0.06 | -3.59 |
| Stochastic Oscillator | 6.49 | 11.77 |
Annaly Capital Management Inc is an American mortgage real estate investment trust. Its business objective is to generate net income for distribution to its stockholders and optimize its returns through prudent management of its diversified investment strategies. The company's reportable operating segments are; the Agency segment, which invests in Agency mortgage-backed securities collateralized by residential mortgages; the Residential Credit segment, which invests in non-Agency residential whole loans and securitized products within the residential and commercial markets; the Mortgage Servicing Rights segment; and Corporate & Other. Maximum revenue for the company is generated from its Agency segment.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.